Lung injury induced by sepsis: Lessons learned from large animal models and future directions for treatment

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 12, 2011, Pages 1169-1178

  Sadowitz, Benjamin ^a   Roy, Shreyas ^a   Gatto, Louis A ^b   Habashi, Nader ^c   Nieman, Gary ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

acute lung injury; acute respiratory distress syndrome; ischemia reperfusion; multiple organ dysfunction syndrome; sepsis; systemic inflammatory response syndrome; ventilator induced lung injury

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ARTIFICIAL VENTILATION; DISEASE ASSOCIATION; DISEASE MODEL; HUMAN; LUNG INJURY; NONHUMAN; PERITONITIS; REVIEW; SEPSIS; TREATMENT PLANNING;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; HUMANS; INTUBATION, INTRATRACHEAL; LIPOPOLYSACCHARIDES; LUNG; PROTEIN C; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SHEEP; SPECIES SPECIFICITY; SWINE;

EID: 82455167370     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.141     Document Type: Review

References (56)

1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N. Engl. J. Med. 340(3), 207-214 (1999).
2. Russell JA. Management of sepsis. N. Engl. J. Med. 355(16), 1699-1713 (2006).
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care. Med. 29(7), 1303-1310 (2001).
4. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit. Care Med. 34(1), 15-21 (2006).
5. Sevransky JE, Levy MM, Marini JJ. Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit. Care Med. 32(Suppl. 11), S548-S553 (2004).
6. Bernard GR, Artigas A, Brigham KL et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149(3 Pt 1), 818-824 (1994).
7. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit. Care Med. 25(7), 1095-1100 (1997).
8. Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit. Care Med. 37(Suppl. 1), S30-S37 (2009).
9. Roy SK, Kendrick D, Sadowitz BD et al. Jack of all trades: pleiotropy and the application of chemically modified tetracycline-3 in sepsis and the acute respiratory distress syndrome (ARDS).Pharmacol. Res. 64(6), 580-589 (2011).
10. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. N. Engl. J. Med. 342(18), 1301-1308 (2000).
11. Bosma KJ, Lewis JF. Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Exp. Opin. Emerg. Drugs 12(3), 461-477 (2007).
12. Del Sorbo L, Slutsky AS. Acute respiratory distress syndrome and multiple organ failure. Curr. Opin. Crit. Care 17(1), 1-6 (2011).
13. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Ann. Rev. Biochem. 71, 635-700 (2002).
14. Vincent JL, Abraham E. The last 100 years of sepsis. Am. J. Respir. Crit. Care Med. 173(3), 256-263 (2006).
15. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock 30(Suppl. 1), S53-S59 (2008).
16. Parker SJ, Watkins PE. Experimental models of Gram-negative sepsis. Br. J. Surg. 88(1), 22-30 (2001).
17. Hubbard WJ, Choudhry M, Schwacha MG et al. Cecal ligation and puncture. Shock 24(Suppl. 1), S52-S57 (2005).
18. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 9(1) 1-11 (1998).
19. Costa EL, Musch G, Winkler T et al. Mild endotoxemia during mechanical ventilation produces spatially heterogeneous pulmonary neutrophilic inflammation in sheep. Anesthesiology 112(3), 658-669 (2010).
20. Fernandez-Bustamante A, Easley RB, Fuld M, Mulreany D, Hoffman EA, Simon BA. Regional aeration and perfusion distribution in a sheep model of endotoxemic acute lung injury characterized by functional computed tomography imaging. Crit. Care Med. 37(8), 2402-2411 (2009).
21. Waerhaug K, Kuzkov VV, Kuklin VN et al. Inhaled aerosolised recombinant human activated protein C ameliorates endotoxin-induced lung injury in anaesthetised sheep. Crit. Care 13(2), R51 (2009).
22. Kuklin V, Kirov M, Sovershaev M et al. Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C. Crit. Care 9(3), R211-R217 (2005).
23. Kuklin VN, Kirov MY, Evgenov OV et al. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit. Care Med. 32(3), 766-773 (2004).
24. Kirov MY, Evgenov OV, Bjertnaes LJ. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep. Crit. Care Med. 31(1), 179-186 (2003).
25. Waerhaug K, Kuklin VN, Kirov MY et al. Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep. Crit. Care 12(4), R104 (2008).
26. Lutz CJ, Picone A, Gatto LA, Paskanik A, Landas S, Nieman GF. Exogenous surfactant and positive end-expiratory pressure in the treatment of endotoxin-induced lung injury. Crit. Care Med. 26(8), 1379-1389 (1998).
27. Nieman GF, Gatto LA, Paskanik AM, Yang B, Fluck R, Picone A. Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs. Crit. Care Med. 24(6), 1025-1033 (1996).
28. Lutz C, Carney D, Finck C et al. Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 158(3), 840-845 (1998).
29. Gatto L, Kollisch-Singule M, Sadowitz B et al. A 48-hr porcine ischemia/reperfusion and sepsis model of ARDS causes lung histopathology similar to that in humans. Shock 35(1), 18 (2010).
30. de Azevedo LC, Park M, Noritomi DT, Maciel AT, Brunialti MK, Salomao R. Characterization of an animal model of severe sepsis associated with respiratory dysfunction. Clinics (Sao Paulo) 62(4), 491-498 (2007).
31. Hauser B, Barth E, Bassi G et al. Hemodynamic, metabolic, and organ function effects of pure oxygen ventilation during established fecal peritonitis-induced septic shock. Crit. Care Med. 37(8), 2465-2469 (2009).
32. Barth E, Bassi G, Maybauer DM et al. Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit. Care Med. 36(2), 495-503 (2008).
33. Kubiak BD, Albert SP, Gatto LA et al. A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury. J. Surg. Res. 166(1), e59-e69 (2011).
34. Steinberg J, Halter J, Schiller H et al. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Shock 24(4), 348-356 (2005).
35. Dellinger RP, Levy MM, Carlet JM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit. Care Med. 36(1), 296-327 (2008).
36. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345(19), 1368-1377 (2001).
37. Talmor D, Sarge T, Malhotra A et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N. Engl. J. Med. 359(20), 2095-2104 (2008).
38. Ferguson ND, Chiche JD, Kacmarek RM et al. Combining high-frequency oscillatory ventilation and recruitment maneuvers in adults with early acute respiratory distress syndrome: the treatment with oscillation and an open lung strategy (TOOLS) trial pilot study. Crit. Care Med. 33(3), 479-486 (2005).
39. Navarrete-Navarro P, Rodriguez A, Reynolds N et al. Acute respiratory distress syndrome among trauma patients: trends in ICU mortality, risk factors, complications and resource utilization. Intensive Care Med. 27(7), 1133-1140 (2001).
40. Shiber J, Habashi N, O'Toole R. APRV is associated with a low rate of ARDS in high-risk trauma patients. Crit. Care Med. 27(12), A185 (2009).
41. Shang GH, Lin DJ, Xiao W et al. Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model. Respir. Res. 10, 91 (2009).
42. Shimizu M, Hasegawa N, Nishimura T et al. Effects of TNF-a-converting enzyme inhibition on acute lung injury induced by endotoxin in the rat. Shock 32(5), 535-540 (2009).
43. Li QF, Zhu YS, Jiang H, Xu H, Sun Y. Isoflurane preconditioning ameliorates endotoxin-induced acute lung injury and mortality in rats. Anesth. Analg. 109(5), 1591-1597 (2009).
44. Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T. Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit. Care 12(2), R43 (2008).
45. Ikegami M, Scoville EA, Grant S et al. Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation. Chest 132(5), 1447-1454 (2007).
46. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179(3), 1855-1863 (2007).
47. Bashenko Y, Ilan N, Krausz MM, Vlodavsky I, Hirsh MI. Heparanase pretreatment attenuates endotoxin-induced acute lung injury in rats. Shock 28(2), 207-212 (2007).
48. Slofstra SH, Groot AP, Maris NA, Reitsma PH, Cate HT, Spek CA. Inhalation of activated protein C inhibits endotoxin-induced pulmonary inflammation in mice independent of neutrophil recruitment. Br. J. Pharmacol. 149(6), 740-746 (2006).
49. Takano K, Yamamoto S, Tomita K et al. Successful treatment of acute lung injury with pitavastatin in septic mice: potential role of glucocorticoid receptor expression in alveolar macrophages. J. Pharmacol. Exp. Ther. 336(2), 381-390 (2011).
50. Zhang L, Jin S, Wang C, Jiang R, Wan J. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J. Surg. 34(7), 1676-1683 (2010).
51. Souza YM, Fontes B, Martins JO et al. Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats. Clinics (Sao Paulo) 65(2), 195-202 (2010).
52. Cadirci E, Altunkaynak BZ, Halici Z et al. a-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 33(5), 479-484 (2010).
53. Oliveira GP, Oliveira MB, Santos RS et al. Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit. Care 13(3), R74 (2009).
54. Shen L, Mo H, Cai L et al. Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kB and mitogen-activated protein kinases. Shock 31(5), 500-506 (2009).
55. Fidan H, Sahin O, Yavuz Y et al. Caffeic acid phenethyl ester reduces mortality and sepsis-induced lung injury in rats. Crit. Care Med. 35(12), 2822-2829 (2007).
56. Wu R, Dong W, Zhou M et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am. J. Respir. Crit. Care Med. 176(8), 805-813 (2007).